Rethinking Cardiovascular Screening in Systemic Lupus Erythematosus

REFERENCES

1. 1.↵
   1. Manzi S,
   2. Selzer F,
   3. Sutton-Tyrrell K, et al

   . Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 1999;42:51-60.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Joyce DP,
   2. Berger JS,
   3. Guttmann A, et al.

   Prevalence of cardiovascular events in a population-based registry of patients with systemic lupus erythematosus. Arthritis Res Ther 2024;26:160.

   OpenUrlPubMed
3. 3.↵
   1. Hermansen ML,
   2. Lindhardsen J,
   3. Torp-Pedersen C,
   4. Faurschou M,
   5. Jacobsen S.

   The risk of cardiovascular morbidity and cardiovascular mortality in systemic lupus erythematosus and lupus nephritis: a Danish nationwide population-based cohort study. Rheumatology 2017;56:709-15.

   OpenUrlPubMed
4. 4.↵
   1. Drosos GC,
   2. Vedder D,
   3. Houben E, et al.

   EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis 2022;81:768-79.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Patel H,
   2. Stoots S,
   3. Von Feldt J,
   4. Baker JF.

   Performance of risk score calculators in the identification of coronary artery calcification in patients with systemic lupus erythematosus. J Rheumatol 2026;53:637-44.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Zhu L,
   2. Singh M,
   3. Lele S, et al.

   Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus. Lupus Sci Med 2022;9:e000564.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Choi MY,
   2. Guan H,
   3. Yoshida K, et al.

   Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus. Semin Arthritis Rheum 2024;67:152468.

   OpenUrlPubMed
8. 8.↵
   1. Mortada I,
   2. Odigie-Okon E,
   3. Motiwala A, et al

   . Coronary artery calcium clinical utilization: an update. Curr Probl Cardiol 2026;51:103258.

   OpenUrlPubMed
9. 9.↵
   1. McMahon M,
   2. Seto R,
   3. Skaggs BJ.

   Cardiovascular disease in systemic lupus erythematosus. Rheumatol Immunol Res 2021;2:157-72.

   OpenUrlPubMed
10. 10.↵
    1. Yazdany J,
    2. Tonner C,
    3. Trupin L, et al.

    Provision of preventive health care in systemic lupus erythematosus: data from a large observational cohort study. Arthritis Res Ther 2010;12:R84.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Mosca M,
    2. Tani C,
    3. Aringer M, et al.

    Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice. Autoimmun Rev 2011;10:383-8.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Skaggs BJ,
    2. Grossman J,
    3. Sahakian L, et al.

    A panel of biomarkers associates with increased risk for cardiovascular events in women with systemic lupus erythematosus. ACR Open Rheumatol 2021;3:209-20.

    OpenUrlPubMed
13. 13.↵
    1. Arnett DK,
    2. Blumenthal RS,
    3. Albert MA, et al.

    2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice guidelines. J Am Coll Cardiol 2019;74:1376-414.

    OpenUrlFREE Full Text
14. 14.↵
    1. Kiani AN,
    2. Magder LS,
    3. Post WS, et al.

    Coronary calcification in SLE: comparison with the Multi-Ethnic Study of Atherosclerosis. Rheumatology 2015;54:1976-81.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Gartshteyn Y,
    2. Braverman G,
    3. Mahtani S,
    4. Geraldino-Pardilla L,
    5. Bokhari S,
    6. Askanase A.

    Prevalence of coronary artery calcification in young patients with SLE of predominantly Hispanic and African-American descent. Lupus Sci Med 2019;6:e000330.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Weber BN,
    2. Biery DW,
    3. Petranovic M, et al.

    Prevalence and prognostic value of incidentally detected coronary artery calcium using artificial intelligence among individuals with immune-mediated inflammatory diseases. JACC Cardiovasc Imaging 2026;19:64-75.

    OpenUrlPubMed